- Home
- CXAI vs IBIO Comparison
CXAI vs IBIO Comparison
Compare CXAI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- IBIO
- Stock Information
- Founded
- CXAI N/A
- IBIO 2008
- Country
- CXAI United States
- IBIO United States
- Employees
- CXAI N/A
- IBIO N/A
- Industry
- CXAI EDP Services
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- IBIO Health Care
- Exchange
- CXAI Nasdaq
- IBIO Nasdaq
- Market Cap
- CXAI 22.4M
- IBIO 9.3M
- IPO Year
- CXAI N/A
- IBIO N/A
- Fundamental
- Price
- CXAI $1.09
- IBIO $0.77
- Analyst Decision
- CXAI
- IBIO Strong Buy
- Analyst Count
- CXAI 0
- IBIO 3
- Target Price
- CXAI N/A
- IBIO $4.87
- AVG Volume (30 Days)
- CXAI 430.4K
- IBIO 2.2M
- Earning Date
- CXAI 05-20-2025
- IBIO 05-02-2025
- Dividend Yield
- CXAI N/A
- IBIO N/A
- EPS Growth
- CXAI N/A
- IBIO N/A
- EPS
- CXAI N/A
- IBIO N/A
- Revenue
- CXAI $7,142,000.00
- IBIO $375,000.00
- Revenue This Year
- CXAI $28.54
- IBIO $36.00
- Revenue Next Year
- CXAI $66.67
- IBIO $33.33
- P/E Ratio
- CXAI N/A
- IBIO N/A
- Revenue Growth
- CXAI N/A
- IBIO 650.00
- 52 Week Low
- CXAI $0.76
- IBIO $0.64
- 52 Week High
- CXAI $3.82
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- CXAI 49.03
- IBIO 23.90
- Support Level
- CXAI $1.04
- IBIO $0.76
- Resistance Level
- CXAI $1.21
- IBIO $0.89
- Average True Range (ATR)
- CXAI 0.06
- IBIO 0.17
- MACD
- CXAI -0.01
- IBIO 0.11
- Stochastic Oscillator
- CXAI 33.33
- IBIO 13.60
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.